NITREX Nitinol Guidewires


ev3 Inc. (Plymouth, MN) recently introduced the NITREX Nitinol Guidewire to its line of products designed for peripheral interventional procedures. The new device will replace ev3’s Ultra-Select and FlexFinder Nitinol Guidewire brands. The company states that NITREX guidewires are constructed of a proprietary solid-nitinol core from proximal to distal tip and designed for maximum kink resistance and atraumatic navigation during challenging interventional cases. Among the device’s features are improved coatings, gold tungsten coils for enhanced radiopacity, new shaft stiffness options for crossing or device delivery, and a variety of tip lengths and angles.

Company: ev3 Inc.
Phone: (800) 716-6700

Key Features
• Improved coating
• Gold tungsten coils for enhanced radiopacity
• New shaft stiffness options

Equalizer Balloon Catheter

The Equalizer Balloon Catheter by Boston Scientific Corporation (Natick, MA) offers advanced shaft technology for efficient performance. According to the company, its 7F bi-lumen shaft design configuration provides a deflation rate at least 68% faster than a standard occlusion balloon.* The catheter’s highly radiopaque balloon markers predict proximal and distal balloon margins to facilitate positioning, and its soft, compliant, latex balloon material adapts to anatomical contours.

The available diameter range includes 20 mm, 27 mm, 33 mm, and 40 mm, with a useable catheter length of 65 cm and 100 cm. The Equalizer Balloon Catheter is indicated for temporary vessel occlusion in applications including arteriography, preoperative occlusion, emergency control of hemorrhage, chemotherapeutic drug infusion, and renal opacification procedures.

*Testing completed by Boston Scientific Corporation. Data on file. Bench test results may not necessarily be indicative of clinical performance.

Company: Boston Scientific Corporation
Phone: (800) 225-3238

Key Features
• Bi-lumen shaft design-faster deflation time
• Highly radiopaque balloon markers
• Compliant latex balloon construction

Xpedient Delivery System

Medtronic AVE (Santa Rosa, CA) has incorporated physician feedback into the design of its new Xpedient Delivery System. The device includes a longer, pliant, tapered nosecone and retains the previous system’s easy-to-operate deployment mechanism. According to Medtronic, the tapered nosecone makes Xpedient a viable treatment option for a range of treatable patients because it helps physicians gain access to the aneurysm through tortuous, sometimes calcified arterial anatomies in the legs and groin.
A lubricious coating on the inner wall of the graft allows for easier retraction of the graft cover, requiring less force to deploy the graft into position. AneuRx with the Xpedient Delivery System is available for immediate shipping in the US, with European availability to come soon.

Company: Medtronic AVE, Inc.
Phone: (888) AVE-STNT

Key Features
• Long, pliant, tapered nosecone
• Lubricated inner-wall coating
• Easy-to-operate deployment mechanism

Thrombex PMT System

One of the newest vascular product offerings from Edwards Lifesciences, LLC (Irvine, CA), is the Thrombex PMT System, a percutaneous mechanical thrombectomy device. The Thrombex PMT is an easy-to-use, self-contained system. No additional capital equipment or personnel are needed. The device uses an internal helical screw to macerate thrombus into tiny fragments and vacuum for aspiration. The glass vacuum source enables monitoring of thrombus removal and functions as a collection container for easy disposal.
The device is a 6F catheter with a braided shaft design to enhance pushability, and it is guidewire compatible. Thrombex PMT is CE Marked and available for sale in the US.

Company: Edwards Lifesciences, LLC
Phone: (949) 250-2500

Key Features
• Easy-to-use, self-contained system
• 6F catheter compatible with 6F introducer
• Usable lengths of 60 cm and 120 cm
• .018-inch guidewire compatibility
• Macerates and aspirates


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.